Latest filing published 31 Mar 2022 for COMPASS Pathways plc, €38k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David Y. Norton: trading record in brief
David Y. Norton is a declared insider at 5 companies (board member); the most frequent names are Vivus Inc, Mallinckrodt plc and Syneos Health, Inc. The record holds 37 filings, for trades running from 1 September 2011 to 29 March 2022.
On the open market, the record shows 1 purchase worth €38k and 4 sales worth €49k. Taken together, the sales exceed the purchases by €11k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 12 share grants and 10 option exercises. 2022 to date brings no purchases and 1 sale.
Most recently, on 31 March 2022, the filings show an open-market sale worth €38k in COMPASS Pathways plc. The last purchase on record was published on 13 November 2017, which is 3,283 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Y. Norton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,384 shares@ US$12.48100.0% of flowOrdinary SharesSEC:0001816590-22-000018:0
- 5,080 shares@ US$0.2626100.0% of flowOrdinary SharesSEC:0001235110-21-000021:0
- 21,807 shares@ US$0.433922.6% of flowOrdinary SharesSEC:0000950138-20-000531:0
- 5,080 shares@ US$0.40444.9% of flowOrdinary SharesSEC:0000950138-20-000537:0
- 8,729 shares@ US$2.9669.3% of flowOrdinary SharesSEC:0000950138-20-000259:0
- 19,396 shares0Ordinary SharesSEC:0000950138-19-000310:1
- 8,527 shares@ US$15.2177.1% of flowOrdinary SharesSEC:0000950138-19-000310:0
- 18,947 shares0Ordinary SharesSEC:0000950138-18-000423:0
- 2,521 shares@ US$15.6814.7% of flowOrdinary SharesSEC:0000950138-18-000214:0
- 2,000 shares@ US$22.0217.2% of flowOrdinary SharesSEC:0000950138-17-000750:0Canonical exit: 8 Feb 2018 (T+90)
- 12,500 sharesCommon StockSEC:0001123292-17-001646:0
- 3,125 shares@ US$0.709.0% of flowCommon StockSEC:0001123292-17-001646:1
- 5,601 shares0Ordinary SharesSEC:0000950138-17-000648:0
- 3,125 shares@ US$1.0112.9% of flowCommon StockSEC:0001123292-17-001337:1
- 12,500 sharesCommon StockSEC:0001123292-17-001337:0
- 3,125 shares@ US$1.1715.7% of flowCommon StockSEC:0001123292-17-001144:1
- 12,500 sharesCommon StockSEC:0001123292-17-001144:0
- 2,693 shares0Class A Common StockSEC:0001529193-17-000001:0
- 3,125 shares@ US$1.0815.1% of flowCommon StockSEC:0001123292-17-000336:1
- 12,500 sharesCommon StockSEC:0001123292-17-000336:0
- 3,125 sharesCommon StockSEC:0001123292-16-002918:0
- 781 shares@ US$1.053.6% of flowCommon StockSEC:0001123292-16-002918:1
- 3,125 sharesCommon StockSEC:0001123292-16-002799:0
- 781 shares@ US$1.143.8% of flowCommon StockSEC:0001123292-16-002799:1
- 3,125 sharesCommon StockSEC:0001123292-16-002634:0
25 of 36 declarations
